DST funding will help K.N. Biosciences commercialise IIT Guwahati's natural blue pigment technology, reducing import dependence and boosting India's bio-manufacturing ecosystem
The 12-week certification program is designed to provide students with industry-relevant knowledge through intensive modules across multiple scientific disciplines
The acquisition of Integrace further strengthens the firm's healthcare investment strategy and reflects growing investor confidence in India's branded formulations market
Senior scientists from Lupin, Mankind Pharma | Bharat Serums and Vaccines, Zydus Lifesciences, Panacea Biotec, Veeda Lifesciences, Shilpa Biologicals, Zumutor Biologics, InoRx and Mumbai Biocluster will discuss India's roadmap to becoming a global biosimilars and biologics hub
Zero-tariff access under the India-UK CETA is expected to boost generic medicine exports, strengthen supply chains and deepen investment and R&D partnerships
Company says active ingredient is clearly disclosed on all Aciloc packs and pledges full cooperation with authorities
Rs. 1,060-crore acquisition strengthens NATCO’s long-term growth strategy in the African pharmaceutical market
Exclusive marketing alliance brings gastro-protective pain management therapy for patients requiring long-term NSAID treatment
Supply chain veteran with over 24 years of experience to strengthen distribution and logistics operations
The event will welcome women across age groups and fitness levels, reinforcing its message that health and fitness are for everyone
The acquisition strengthens NATCO Pharma's strategic presence in the African pharmaceutical market through Adcock Ingram, one of South Africa's leading pharmaceutical manufacturers and healthcare companies
Apollo-managed funds and affiliates will acquire a minority, non-controlling stake in a newly established entity
The acquisition brings together Novartis’ global oncology capabilities with Myricx Bio’s pioneering N-myristoyltransferase inhibitor (NMTi) payload platform
The drug is bioequivalent and therapeutically equivalent to the reference listed drug, Zyprexa IntraMuscular Injection
The India FMCG business maintained its growth momentum during the quarter
Meanwhile, US-based facilities have seen their share remain unchanged at 18% since 2024
This prestigious certification is based entirely on the experiences shared by current employees of the company
Subscribe To Our Newsletter & Stay Updated
